<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-IAI-2691</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-2691</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КРАТКИЕ СООБЩЕНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>SHORT COMMUNICATIONS</subject></subj-group></article-categories><title-group><article-title>IL-4 и его полиморфизм (IL4-589C/T) при цервикальной неоплазии</article-title><trans-title-group xml:lang="en"><trans-title>IL-4 and its polymorphism (IL4-589C/T) in cervical neoplasia</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7559-5246</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Абакумова</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Abakumova</surname><given-names>T. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Абакумова Татьяна Владимировна — доктор биологических наук, доцент, профессор кафедры физиологии и патофизиологии Института медицины, экологии и физической культуры.</p><p>Ульяновск</p></bio><bio xml:lang="en"><p>Tatyana V. Abakumova - PhD, MD (Biology), Associate Professor, Professor, Department of Physiology and Pathophysiology, Institute of Medicine, Ecology and Physical Culture, Ulyanovsk State University.</p><p>Ulyanovsk</p></bio><email xlink:type="simple">taty-abakumova@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3908-0840</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мягдиева</surname><given-names>И. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Myagdieva</surname><given-names>I. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мягдиева Ильсея Ринатовна — ассистент, аспирант кафедры физиологии и патофизиологии Института медицины, экологии и физической культуры.</p><p>4321017, Ульяновск, ул. Л. Толстого, 42</p><p>Тел.: 8 (937) 039-85-86</p></bio><bio xml:lang="en"><p>Ilseya R. Myagdieva - Assistant Professor, Postgraduate Student, Department of Physiology and Pathophysiology, Institute of Medicine, Ecology and Physical Culture, Ulyanovsk State University.</p><p>42 Leo Tolstoy St, Ulyanovsk 432017</p><p>Phone: +7 (937) 039-85-86</p></bio><email xlink:type="simple">ilseya2015@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5475-7031</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Долгова</surname><given-names>Д. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Dolgova</surname><given-names>D. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Долгова Динара Ришатовна — кандидат биологических наук, доцент, доцент кафедры физиологии и патофизиологии Института медицины, экологии и физической культуры.</p><p>Ульяновск</p></bio><bio xml:lang="en"><p>Dinara R. Dolgova - PhD (Biology), Associate Professor, Department of Physiology and Pathophysiology, Institute of Medicine, Ecology and Physical Culture, Ulyanovsk State University.</p><p>Ulyanovsk</p></bio><email xlink:type="simple">dolgova.dinara@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6970-6659</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Генинг</surname><given-names>С. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Gening</surname><given-names>S. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Генинг Снежанна Олеговна — кандидат медицинских наук, старший преподаватель кафедры физиологии и патофизиологии Института медицины, экологии и физической культуры.</p><p>Ульяновск</p></bio><bio xml:lang="en"><p>Snezhanna O. Gening - PhD (Medicine), Assistant Professor, Department of Physiology and Pathophysiology, Institute of Medicine, Ecology and Physical Culture, Ulyanovsk State University.</p><p>Ulyanovsk</p></bio><email xlink:type="simple">sgening@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1525-2070</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Антонеева</surname><given-names>И. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Antoneeva</surname><given-names>I. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Антонеева Инна Ивановна — доктор медицинских наук, профессор, профессор кафедры онкологии и лучевой диагностики ФГБОУ ВО «УлГУ»; заведующая гинекологическим отделением ГУЗ «ОКОД».</p><p>Ульяновск</p></bio><bio xml:lang="en"><p>Inna I. Antoneeva - PhD, MD (Medicine), Professor, Department of Oncology and Radiation Diagnostics, Ulyanovsk State University; Head of the Gynecological Department, Regional Clinical Oncologic Center.</p><p>Ulyanovsk</p></bio><email xlink:type="simple">aii72@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5117-1382</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Генинг</surname><given-names>Т. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Gening</surname><given-names>T. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Генинг Татьяна Петровна — доктор биологических наук, профессор, заведующая кафедрой физиологии и патофизиологии.</p><p>Ульяновск</p></bio><bio xml:lang="en"><p>Tatyana P. Gening - PhD, MD (Biology), Professor, Head, Department of Physiology and Pathophysiology, Ulyanovsk State University.</p><p>Ulyanovsk</p></bio><email xlink:type="simple">Naum-53@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Ульяновский государственный университет»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ulyanovsk State University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Ульяновский государственный университет»; ГУЗ «Областной клинический онкологический диспансер»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ulyanovsk State University; Regional Clinical Oncologic Center</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>01</day><month>06</month><year>2023</year></pub-date><volume>25</volume><issue>5</issue><fpage>1129</fpage><lpage>1134</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Абакумова Т.В., Мягдиева И.Р., Долгова Д.Р., Генинг С.О., Антонеева И.И., Генинг Т.П., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Абакумова Т.В., Мягдиева И.Р., Долгова Д.Р., Генинг С.О., Антонеева И.И., Генинг Т.П.</copyright-holder><copyright-holder xml:lang="en">Abakumova T.V., Myagdieva I.R., Dolgova D.R., Gening S.O., Antoneeva I.I., Gening T.P.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/2691">https://www.mimmun.ru/mimmun/article/view/2691</self-uri><abstract><p>Переход неоплазии шейки матки (CIN) в рак шейки матки происходит при активном участии IL-4, для которого показано как про-, так и противоопухолевое действие при опухолях различной локализации. Экспрессия цитокинов регулируется на уровне транскрипции в промоторной области гена. Показано, что генотип IL4 (589C/T) (rs2243250) ассоциирован с развитием рака желудка и молочной железы. Вклад вариаций генотипа IL4 в развитие CIN еще не изучен. Цель исследования — оценить риск развития неоплазии шейки матки по наличию полиморфизма IL4 (589C/T) и уровню IL-4.</p><p>Объектом исследования служили циркулирующие нейтрофилы, сыворотка и геномная ДНК 36 больных CIN и 20 женщин без дисплазии (группа сравнения). С помощью ИФА определяли уровень IL-4 в лизате нейтрофилов и сыворотке крови. Оценивали фагоцитарную активность и способность нейтрофилов к адгезии (CD11b). Аллель-специфическую ПЦР в реальном времени с использованием зондов Taq-Man использовали для анализа IL4 589C/T (rs2243250). Статистическую обработку проводили с помощью программ Statistica 13 и Jamovi 1.6.5.0.</p><p>В результате исследования установлено, что уровень IL-4 в сыворотке крови и циркулирующих нейтрофилах у больных с CIN достоверно выше, чем в группе сравнения. Аллель -589С* гена IL4 и генотип ТТ чаще встречаются в группе с CIN (55,5%), чем в контроле (25%). При этом установлена прямая связь между наличием полиморфизма и повышенной адгезивной способностью и с показателями фагоцитарного числа циркулирующих нейтрофилов. Анализ частоты встречаемости IL4 С589Т методом «случай-контроль» показал, что шансы формирования CIN у носителей аллеля -589С и генотипа ТТ составили 3,75 (95% ДИ: 1,013-13,880, Хи-квадрат = 4,161, р = 0,042). Аллель -589C* и TT генотип IL4, уровни нейтрофилов и сывороточного IL-4 связаны с инфекцией ВПЧ. С помощью модели бинарной логистической регрессии показана возможность использования уровней IL-4 в циркулирующих нейтрофилах и полиморфизма IL4 (589C/T) для дифференциальной диагностики пациентов с CIN (χ2 = 15,6, p = 0,001). Значимость их сочетания оценивали с помощью анализа ROC-кривых (IL-4 в нейтрофилах; IL4 (-589С*), вероятность 75%).</p><p>Таким образом, IL-4 (589C/T) связан с адгезивной и фагоцитарной активностью циркулирующих нейтрофилов. У ВПЧ-инфицированных пациентов полиморфизм гена IL-4 (589C/T) может служить маркером раннего выявления и прогноза CIN.</p></abstract><trans-abstract xml:lang="en"><p>The transition of cervical neoplasia (CIN) to cervical cancer occurs with the active participation of IL-4, for which both pro- and antitumor effects have been shown with tumors of various localizations. The expression of cytokines is regulated at the transcriptional level in the promoter region of the gene. It has been shown that the genotype IL4 (589C/T) (rs2243250) is associated with the development of gastric and breast cancer. The contribution of IL-4 genotypic variations to the development of CIN has not yet been studied. The aim of the study was to assess the risk of developing cervical neoplasia by the presence polymorphism of IL4 (589C/T) and the level of IL-4. The object of the study was circulating neutrophils, serum and genomic DNA of 36 patients with CIN and 20 women without dysplasia (comparison group). Using ELISA, the level of IL-4 was determined in neutrophil lysate and serum. Phagocytic activity and adhesive ability (CD11b) of neutrophils were assessed. Allele-specific real-time PCR using Taq-Man probes was used to analyze of the IL4 589C/T (rs2243250). Statistical processing was carried out using Statistica 13 and Jamovi 1.6.5.0. As a result of the study, it was found that the level of IL-4 in serum and circulating neutrophils in patients with CIN is significantly higher than in the comparison group. The -589C* allele of the IL4 gene and the TT genotype are more common in the group with CIN (55.5%) than in the control (25%). At the same time, a direct relationship was established between the presence of polymorphism and increased adhesive ability and with indicators of the phagocytic number of circulating neutrophils. Analysis of the incidence of IL4 C589T by the «case-control» method showed that the chances of CIN formation in carriers of the -589C allele and the TT genotype were 3.75 (95% CI: 1.013 - 13.880, Chi-square = 4.161, p = 0.042). The -589C* allele and TT IL4 genotype, neutrophil and serum IL-4 levels are associated with HPV infection. Using a binary logistic regression model, we demonstrated the possibility of using IL-4 levels in circulating neutrophils and IL-4 gene polymorphism (589C/T) for the differential diagnosis of patients with CIN (χ2 = 15.6, p = 0.001). Significant significance for their combination was assessed by ROC-curve analysis (IL-4 in neutrophils; IL4 (-589С*), 75% probability. Thus, the IL4 (589C/T) is associated with the adhesive and phagocytic activity of circulating neutrophils. In HPV-infected patients, IL4 gene polymorphism (589C/T) can serve as a marker for early detection and prognosis of CIN.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>IL-4</kwd><kwd>полиморфизм IL4 (589C/T)</kwd><kwd>цервикальная интраэпителиальная неоплазия</kwd><kwd>нейтрофилы</kwd><kwd>ВПЧ</kwd><kwd>дифференциальная диагностика</kwd></kwd-group><kwd-group xml:lang="en"><kwd>IL-4</kwd><kwd>IL4 polymorphism (589C/T)</kwd><kwd>neutrophils</kwd><kwd>cervical intraepithelial neoplasia</kwd><kwd>HPV</kwd><kwd>differential diagnosis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Amsen D., Spilianakis C.G., Flavell R.A. How are T(H)1 and T(H)2 effector cells made? Curr. Opin. Immunol., 2009, Vol. 21, no. 2, pp. 153-160.</mixed-citation><mixed-citation xml:lang="en">Amsen D., Spilianakis C.G., Flavell R.A. How are T(H)1 and T(H)2 effector cells made? Curr. Opin. Immunol., 2009, Vol. 21, no. 2, pp. 153-160.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Balaji D., Kalarani I.B., Mohammed V., Veerabathiran R. Potential role of human papillomavirus proteins associated with the development of cancer. Virusdisease, 2022, Vol. 33, no. 3, pp. 322-333.</mixed-citation><mixed-citation xml:lang="en">Balaji D., Kalarani I.B., Mohammed V., Veerabathiran R. Potential role of human papillomavirus proteins associated with the development of cancer. Virusdisease, 2022, Vol. 33, no. 3, pp. 322-333.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Brandt E., Woerly G., Younes A.B., Loiseau S., Capron M. IL-4 production by human polymorphonuclear neutrophils. J. Leukoc. Biol., 2000, Vol. 68, no. 1, pp. 125-130.</mixed-citation><mixed-citation xml:lang="en">Brandt E., Woerly G., Younes A.B., Loiseau S., Capron M. IL-4 production by human polymorphonuclear neutrophils. J. Leukoc. Biol., 2000, Vol. 68, no. 1, pp. 125-130.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Chatterjee A., Rathore A., Dhole T.N. Association of IL-4 589 C/T promoter and IL-4RalphaI50V receptor polymorphism with susceptibility to HIV-1 infection in North Indians. J. Med. Virol., 2009, Vol. 81, no. 6, pp. 959-965.</mixed-citation><mixed-citation xml:lang="en">Chatterjee A., Rathore A., Dhole T.N. Association of IL-4 589 C/T promoter and IL-4RalphaI50V receptor polymorphism with susceptibility to HIV-1 infection in North Indians. J. Med. Virol., 2009, Vol. 81, no. 6, pp. 959-965.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Girard D., Paquin R., Beaulieu A.D. Responsiveness of human neutrophils to interleukin-4: induction of cytoskeletal rearrangements, de novo protein synthesis and delay of apoptosis. Biochem. J., 1997, Vol. 325, Pt 1, pp. 147-153.</mixed-citation><mixed-citation xml:lang="en">Girard D., Paquin R., Beaulieu A.D. Responsiveness of human neutrophils to interleukin-4: induction of cytoskeletal rearrangements, de novo protein synthesis and delay of apoptosis. Biochem. J., 1997, Vol. 325, Pt 1, pp. 147-153.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Jia Y., Xie X., Shi X., Li S. Associations of common IL-4 gene polymorphisms with cancer risk: A meta-analysis. Mol. Med. Rep., 2017, Vol. 16, no. 2, pp. 1927-1945.</mixed-citation><mixed-citation xml:lang="en">Jia Y., Xie X., Shi X., Li S. Associations of common IL-4 gene polymorphisms with cancer risk: A meta-analysis. Mol. Med. Rep., 2017, Vol. 16, no. 2, pp. 1927-1945.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ma J., Zhu S., Liu Z., Mao Y., Li X., Dai L., Zhao X., Wei C., Liu J., Geng Y. Clinical value of cytokine assay in diagnosis and severity assessment of lung cancer. Evid. Based Complement. Alternat. Med., 2022, Vol. 2022, 4641600. doi: 10.1155/2022/4641600.</mixed-citation><mixed-citation xml:lang="en">Ma J., Zhu S., Liu Z., Mao Y., Li X., Dai L., Zhao X., Wei C., Liu J., Geng Y. Clinical value of cytokine assay in diagnosis and severity assessment of lung cancer. Evid. Based Complement. Alternat. Med., 2022, Vol. 2022, 4641600. doi: 10.1155/2022/4641600.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Mohammed T.F., Qadir F.A. Detection of IL-1 в, VEGF and IL-4 with their novel genetic variations in breast cancer patients. Saudi J. Biol. Sci., 2023, Vol. 30, no. 2, 103544. doi: 10.1016/j.sjbs.2022.103544.</mixed-citation><mixed-citation xml:lang="en">Mohammed T.F., Qadir F.A. Detection of IL-1 в, VEGF and IL-4 with their novel genetic variations in breast cancer patients. Saudi J. Biol. Sci., 2023, Vol. 30, no. 2, 103544. doi: 10.1016/j.sjbs.2022.103544.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Rodionov S.J., Chereshnev V.A., Orlova E.G., Taranenko L.A., Sibiryak S.V., Orlov O.A., Shur N.N., Krapivina O.A., Sukhovata D.A. Serum cytokine concentrations in oncologic patients during immuno- and polychemotherapies with application of human alpha-fetoprotein. Cytokines and Inflammation, 2007, Vol. 6, no. 3, pp. 36-39. (In Russ.)</mixed-citation><mixed-citation xml:lang="en">Rodionov S.J., Chereshnev V.A., Orlova E.G., Taranenko L.A., Sibiryak S.V., Orlov O.A., Shur N.N., Krapivina O.A., Sukhovata D.A. Serum cytokine concentrations in oncologic patients during immuno- and polychemotherapies with application of human alpha-fetoprotein. Cytokines and Inflammation, 2007, Vol. 6, no. 3, pp. 36-39. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Shevchenko A.V., Golovanova O.V., Kolomejtchuk M.Ju., Konenkov V.l., Garbukov E.Ju., Stakheeva M.N. Promotor polymorphism of IL-4, IL-6, and IL-10 genes among patients with breast cancer. Medical Immunology (Russia), 2009, Vol. 11, no. 1, pp. 21-28. doi: 10.15789/1563-0625-2009-1-21-28.</mixed-citation><mixed-citation xml:lang="en">Shevchenko A.V., Golovanova O.V., Kolomejtchuk M.Ju., Konenkov V.l., Garbukov E.Ju., Stakheeva M.N. Promotor polymorphism of IL-4, IL-6, and IL-10 genes among patients with breast cancer. Medical Immunology (Russia), 2009, Vol. 11, no. 1, pp. 21-28. doi: 10.15789/1563-0625-2009-1-21-28.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Tan N., Song J., Yan M., Wu J., Sun Y., Xiong Z., Ding Y. Association between IL-4 tagging single nucleotide polymorphisms and the risk of lung cancer in China. Mol. Genet. Genomic Med., 2019, Vol. 7, no. 4, e00585. doi: 10.1002/mgg3.585.</mixed-citation><mixed-citation xml:lang="en">Tan N., Song J., Yan M., Wu J., Sun Y., Xiong Z., Ding Y. Association between IL-4 tagging single nucleotide polymorphisms and the risk of lung cancer in China. Mol. Genet. Genomic Med., 2019, Vol. 7, no. 4, e00585. doi: 10.1002/mgg3.585.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Tuguz A.R., Anisimova N.Yu., Vershinina M.Yu., Kiselevsky M.V. A corelation of the main blood cytokines in oncology patients and in healthy donors. Immunologiya, 2003, Vol. 24, no. 3, pp. 184-186. (In Russ.)</mixed-citation><mixed-citation xml:lang="en">Tuguz A.R., Anisimova N.Yu., Vershinina M.Yu., Kiselevsky M.V. A corelation of the main blood cytokines in oncology patients and in healthy donors. Immunologiya, 2003, Vol. 24, no. 3, pp. 184-186. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Vuletic A.M., Konjevic G.M., Larsen A.K., Babovic N.L., Jurisic VB., Krivokuca A., Mirjacic Martinovic K.M. Interleukin-4-induced natural killer cell antitumor activity in metastatic melanoma patients. Eur. Cytokine Netw., 2020. doi: 10.1684/ecn.2020.0449.</mixed-citation><mixed-citation xml:lang="en">Vuletic A.M., Konjevic G.M., Larsen A.K., Babovic N.L., Jurisic VB., Krivokuca A., Mirjacic Martinovic K.M. Interleukin-4-induced natural killer cell antitumor activity in metastatic melanoma patients. Eur. Cytokine Netw., 2020. doi: 10.1684/ecn.2020.0449.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Y., Li H., Wang X., Gao F., Yu L., Chen X. Association between four SNPs in IL-4 and the risk of gastric cancer in a Chinese population. Int. J. Mol. Epidemiol. Genet., 2017, Vol. 8, no. 4, pp. 45-52.</mixed-citation><mixed-citation xml:lang="en">Wang Y., Li H., Wang X., Gao F., Yu L., Chen X. Association between four SNPs in IL-4 and the risk of gastric cancer in a Chinese population. Int. J. Mol. Epidemiol. Genet., 2017, Vol. 8, no. 4, pp. 45-52.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao J., Zuo H., Ding K., Zhang X., Bi Z., Cheng H. Changes in plasma IL-1 в, TNF-a and IL-4 levels are involved in chemotherapy-related cognitive impairment in early-stage breast cancer patients. Am. J. Transl. Res., 2020, Vol. 12, no. 6, pp. 3046-3056.</mixed-citation><mixed-citation xml:lang="en">Zhao J., Zuo H., Ding K., Zhang X., Bi Z., Cheng H. Changes in plasma IL-1 в, TNF-a and IL-4 levels are involved in chemotherapy-related cognitive impairment in early-stage breast cancer patients. Am. J. Transl. Res., 2020, Vol. 12, no. 6, pp. 3046-3056.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
